導管插入鞘套市場機會、成長要素、產業趨勢分析及2026-2035年預測。

全球導管插入鞘套市場預計到 2025 年價值 13 億美元，預計到 2035 年將以 6.7% 的複合年成長率成長至 25 億美元。

這一成長主要源自於需要精準可靠血管通路介入手術數量的增加。醫療機構越來越重視能夠提升病人安全並提高手術效率的技術。導管鞘套能夠實現對體內路徑的精準控制，在診斷和治療應用中發揮至關重要的作用。微創治療方法的普及進一步加速了該產品在醫療機構的應用。此外，慢性病盛行率的上升也促進了手術數量的增加，從而增強了市場需求。隨著醫療機構尋求能夠確保精準性、減少併發症並改善整體臨床療效的可靠解決方案，設備設計的不斷改進和醫療基礎設施的不斷完善正在進一步推動市場成長。

導管鞘套是引導導管安全有效地進入體內的重要醫療器材。它們起到保護性通道的作用，減少插入過程中的組織損傷，並支持導管在體內順暢移動。導管鞘的使用有助於最大限度地減少併發症，並改善治療效果。介入治療需求的不斷成長，推動了對能夠確保精準性和安全性的可靠通路裝置的需求。隨著醫療系統不斷採用微創方法和門診模式，高效且易於使用的裝置的重要性日益凸顯，進一步鞏固了導引鞘在現代臨床實踐中的作用。

預計到2035年，整合式導引鞘市場將以7%的複合年成長率成長，達到15億美元。此細分市場的成長主要得益於對支援先進手術流程的精簡高效醫療設備日益成長的需求。整合式設計透過減少操作步驟，提高了無菌性並降低了污染風險。這些系統還簡化了工作流程，減少了手術過程中所需的零件數量，從而帶來了操作優勢，使其成為醫療機構更具成本效益的選擇。

截至2025年，醫院市佔率佔比達62.3%。這些機構在進行各種需要精準血管通路的複雜醫療手術中持續扮演核心角色。在高壓臨床環境中，對高效可靠工具的需求不斷成長，並持續推動導管導引鞘的需求。此外，醫院在急診醫療中也扮演著至關重要的角色，快速介入和精準操作在急診醫療中至關重要，這進一步鞏固了醫院在市場上的主導地位。

美國導管鞘套市場預計到2025年將達到3.975億美元，並在2026年至2035年間以4.6%的複合年成長率成長。市場擴張的主要驅動力是醫療模式轉移到門診以及微創手術需求日益成長的成長。門診手術數量的增加促進了導引鞘的廣泛應用。此外，為改善醫療效果和擴大早期診斷及治療的覆蓋範圍而持續進行的工作，也進一步推動了手術數量的成長，並支撐著市場的持續發展。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策和資料完整性計劃
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 調查過程的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 每種方法中基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 心血管和神經血管疾病盛行率增加
    • 導管插入鞘套的技術進步
    • 已開發國家的優惠還款政策
    • 微創手術技術的廣泛應用
  • 產業潛在風險與挑戰
    • 產品核可有嚴格的監理要求
    • 導引鞘高成本
  • 市場機遇
    • 迅速轉向經經皮治療
• 成長潛力分析
• 監理情勢
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技趨勢
  • 當前技術趨勢
  • 新興技術
• 未來市場趨勢（基於初步研究）
• 人工智慧和生成式人工智慧對市場的影響
• 客戶洞察（基於初步研究）
• 2025年價格分析
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 競爭定位矩陣
• 主要市場公司的競爭分析
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品類型發布
  • 業務拓展計劃

第5章 市場估價與預測：依產品分類，2022-2035年

• 一體式安裝鞘套
• 可分離式導入鞘套

第6章 市場估計與預測：依應用領域分類，2022-2035年

• 循環系統
• 神經血管
• 泌尿系統
• 婦科
• 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

• 醫院
• 門診手術中心
• 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Abbott
• B Braun
• BD
• CONMED
• COOK MEDICAL
• Cordis
• Integer
• LEPU MEDICAL
• Medtronic
• MERIT MEDICAL
• Stryker
• Terumo
• GORE

The Global Catheter Introducer Sheaths Market was valued at USD 1.3 billion in 2025 and is estimated to grow at a CAGR of 6.7% to reach USD 2.5 billion by 2035.

Growth is driven by the growing volume of interventional procedures that require precise and reliable vascular access. Healthcare providers are increasingly prioritizing technologies that improve procedural efficiency while enhancing patient safety. Catheter introducer sheaths play a critical role in enabling controlled access to internal pathways, supporting both diagnostic and therapeutic applications. The shift toward less invasive treatment approaches is further accelerating product adoption across healthcare settings. Additionally, the rising prevalence of chronic conditions is contributing to increased procedural volumes, strengthening market demand. Continuous improvements in device design, along with the expansion of healthcare infrastructure, are further supporting market growth as providers seek reliable solutions that ensure accuracy, reduce complications, and enhance overall clinical outcomes.

Catheter introducer sheaths are essential medical tools that assist in guiding catheters into the body safely and efficiently. They serve as protective conduits that help reduce tissue damage during insertion while supporting smooth navigation within internal pathways. Their use contributes to minimizing complications and improving procedural outcomes. The increasing demand for interventional procedures is driving the need for reliable access devices that support precision and safety. As healthcare systems continue to adopt minimally invasive approaches and outpatient care models, the importance of efficient and easy-to-use devices is growing, reinforcing the role of introducer sheaths in modern clinical practices.

The integrated introducer sheaths segment is expected to grow at a CAGR of 7% and reach USD 1.5 billion by 2035. Growth in this segment is being driven by increasing demand for streamlined and efficient medical devices that support advanced procedures. Integrated designs enhance sterility by reducing handling steps, which lowers the risk of contamination. These systems also offer operational advantages by simplifying workflows and reducing the number of components required during procedures, making them a cost-effective option for healthcare providers.

The hospitals segment accounted for 62.3% share in 2025. These facilities remain central to performing a wide range of complex medical procedures that require precise vascular access. The need for efficient and reliable tools in high-pressure clinical environments continues to support demand for introducer sheaths. Hospitals also play a key role in managing urgent medical conditions, where rapid access and procedural accuracy are critical, further reinforcing their dominance in the market.

United States Catheter Introducer Sheaths Market was valued at USD 397.5 million in 2025 and is projected to grow at a CAGR of 4.6% from 2026 to 2035. Market expansion is being supported by the increasing shift toward outpatient care and the growing preference for minimally invasive procedures. The rising number of procedures performed in ambulatory settings is contributing to higher utilization of introducer sheaths. In addition, ongoing efforts to improve healthcare outcomes and expand access to early diagnosis and treatment are further driving procedural volumes, supporting sustained market growth.

Key companies operating in the Global Catheter Introducer Sheaths Market include Medtronic, Abbott, BD, Terumo, Stryker, B Braun, CONMED, COOK MEDICAL, Cordis, Integer, LEPU MEDICAL, MERIT MEDICAL, and GORE. Companies in the Global Catheter Introducer Sheaths Market are focusing on innovation, product efficiency, and strategic expansion to strengthen their market position. They are investing in research and development to design advanced devices that improve safety, reduce procedural complexity, and enhance clinical outcomes. Many players are introducing integrated and user-friendly solutions that streamline workflows and support infection control. Strategic collaborations and partnerships with healthcare providers are helping companies expand their reach and improve product adoption. Additionally, firms are strengthening their distribution networks and enhancing manufacturing capabilities to meet rising demand. A strong emphasis on regulatory compliance, quality standards, and continuous product improvement is also enabling companies to maintain a competitive edge in the evolving healthcare landscape.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular and neurovascular diseases
    • 3.2.1.2 Technological advancements in catheter introducer sheaths
    • 3.2.1.3 Favorable reimbursement policies in developed economies
    • 3.2.1.4 Growing adoption of minimally invasive procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory requirements for product approval
    • 3.2.2.2 High costs of advanced introducer sheaths
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rapid shift toward percutaneous procedures
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Impact of AI and generative AI on the market
• 3.8 Customer insights (Driven by Primary Research)
• 3.9 Pricing analysis, 2025
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product type launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Integrated introducer sheaths
• 5.3 Separable introducer sheaths

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Cardiovascular
• 6.3 Neurovascular
• 6.4 Urological
• 6.5 Gynecological
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott
• 9.2 B Braun
• 9.3 BD
• 9.4 CONMED
• 9.5 COOK MEDICAL
• 9.6 Cordis
• 9.7 Integer
• 9.8 LEPU MEDICAL
• 9.9 Medtronic
• 9.10 MERIT MEDICAL
• 9.11 Stryker
• 9.12 Terumo
• 9.13 GORE